A Controlled Trial of Abreaction with Lysergic Acid Diethylamide (Lsd-25)

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 1963 English Publisher:Royal College of PsychiatristsJournal:British Journal of Psychiatry, volume 109, pages 46-53 (issn: 0007-1250, eissn: 1472-1465,

Copyright policy )

Authors: J T, ROBINSON; L S, DAVIES; E L, SACK; J D, MORRISSEY;

doi: 10.1192/bjp.109.458.46

pmid: 13974453

A Controlled Trial of Abreaction with Lysergic Acid Diethylamide (Lsd-25)

- Summary
- Subjects
- Metrics

Abstract

All who have used lysergic acid diethylamide (LSD-25) acclaim it as a valuable aid to psychotherapy, regarding it as a “deep” abreactive agent, in that in certain cases it erupts early traumatic experiences as far back as infancy, with appropriate emotional catharsis which is believed to be of considerable therapeutic benefit to the patient. It is also claimed that it facilitates and enhances the transference situation.

Keywords

Psychotherapy, Lysergic Acid Diethylamide, Humans, Abreaction

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	17
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%